GCIA
ZURAW

Gabelli & Co Investment Advisers’s Zura Bio Limited Warrants ZURAW Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ZURAW Stock Details ZURAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-45,700
Closed -$6.86K – 258
2022
Q4 		$6.86K Hold
45,700
– – ﹤0.01% 224
2022
Q3 		$7K Hold
45,700
– – ﹤0.01% 372
2022
Q2 		$8K Hold
45,700
– – ﹤0.01% 398
2022
Q1 		$20K Hold
45,700
– – ﹤0.01% 406
2021
Q4 		$21K Hold
45,700
– – ﹤0.01% 439
2021
Q3 		$27K Buy
+45,700
New +$26.6K ﹤0.01% 419

Other funds holding ZURAW

AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 20.06% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.82% 1-Year Est. Return

Gabelli & Co Investment Advisers's ZURAW Position: Q1 2023 in Review

Gabelli & Co Investment Advisers sold out of Zura Bio Limited Warrants (ZURAW) in Q1 2023, closing a stake of 45,700 shares — an estimated $6.86K sold.

Gabelli & Co Investment Advisers first reported a position in ZURAW in Q3 2021 and held it in 6 quarters. The position peaked at $27K in Q3 2021. 16 funds tracked by Wall St. Rank hold ZURAW as of Q1 2023.

  • Gabelli & Co Investment Advisers reported no remaining Zura Bio Limited Warrants position as of Q1 2023 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 45,700 Zura Bio Limited Warrants shares in Q1 2023, an estimated $6.86K.
  • Gabelli & Co Investment Advisers first reported a position in Zura Bio Limited Warrants in Q3 2021 and held it in 6 quarters.
  • Gabelli & Co Investment Advisers's Zura Bio Limited Warrants position peaked at $27K in Q3 2021.
  • 16 funds tracked by Wall St. Rank held Zura Bio Limited Warrants as of Q1 2023.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2023, filed 12 May 2023.